You are here
Press Releases
For press releases, media inquiries or to speak with a vascular surgeon, contact Beth Bales at (312) 334-2316 or by email. (No solicitors, please.)
June 24, 2021 • Press Release
Exact Symptom Status Better Predicts Outcomes after Transfemoral Carotid Artery Stenting
Further stratification according to preprocedural symptoms in patients undergoing transfemoral carotid artery stenting (TFCAS) improves the preoperative risk assessment, a review of the Society of Vascular Surgery’s Vascular Quality Initiative (VQI) data suggests.
June 22, 2021 • Press Release
The Society for Vascular Surgery (SVS), the leading not-for-profit, professional medical society on establishing causes and treatments for vascular disease, today announced its officers for 2021-2022. Several officers shifted roles and Dr. Joseph L. Mills was elected vice president at the SVS annual business meeting held virtually on June 16, 2021.
June 2, 2021 • Press Release
A single-center retrospective study suggests avoiding Propofol or intra-procedural sedation during catheter-directed interventions (CDIs) for intermediate-risk pulmonary embolism (PE) because it can have detrimental effects. Propofol is the most commonly used parenteral anesthetic agent in the United States, extensively used for minor and outpatient surgical procedures because of its rapid onset and reversal of action, and in intensive care units for maintenance of coma.
April 29, 2021 • Press Release
Neglect can Lead to Nerve Damage, Circulation Issues and Amputation Rosemont, Ill. – April 29, 2021 – Stand up for your feet. That is the message from David Armstrong, DPM, PhD, a member of the Society for Vascular Surgery and a podiatric surgeon. While National Foot Health Awareness Month was recognized in April, the message should resonate always.
April 15, 2021 • Press Release
Rosemont, Illinois, April 14, 2021 – A multicenter retrospective study of the Prospective Observational Vascular Injury Treatment (PROOVIT) registry suggests the use of temporary intravascular shunts (TIVSs) results in lower rates of amputation during the early phase of care and should be part of a more aggressive approach to restore perfusion in the most injured patients and ischemic limbs. The “time is tissue” concept suggests time to reperfusion is a critical factor in saving an extremity that has suffered trauma complicated by arterial injury.
